nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Association between clinical characteristics, acute steroid treatment and oligoclonal bands result in multiple sclerosis: A retrospective study
|
Tolkovsky, Assaf |
|
|
85 |
C |
p. |
artikel |
2 |
Association of oral disease-modifying agents and their adherence trajectories with annual relapses in multiple sclerosis
|
Earla, Jagadeswara Rao |
|
|
85 |
C |
p. |
artikel |
3 |
Asthma and chronic obstructive pulmonary disease (COPD) in people with multiple sclerosis: A systematic review and meta-analysis
|
Ghoshouni, Hamed |
|
|
85 |
C |
p. |
artikel |
4 |
A study of referral bias in NMOSD and MOGAD cohorts
|
Leal Rato, Miguel |
|
|
85 |
C |
p. |
artikel |
5 |
Backwards walking speed reserve in persons with multiple sclerosis
|
Monaghan, Patrick G. |
|
|
85 |
C |
p. |
artikel |
6 |
Blood sphingolipid as a novel biomarker in patients with neuromyelitis optica spectrum disorder
|
Kim, Hyunjin |
|
|
85 |
C |
p. |
artikel |
7 |
Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives
|
Lorefice, L. |
|
|
85 |
C |
p. |
artikel |
8 |
Breakthrough COVID-19 in people with multiple sclerosis on disease modifying treatments: Is it still a severe disease?
|
Immovilli, Paolo |
|
|
85 |
C |
p. |
artikel |
9 |
Burden of treatment and quality of life in relapsing remitting multiple sclerosis patients under early high efficacy therapy in Argentina: Data from the Argentinean registry
|
Rojas, Juan I. |
|
|
85 |
C |
p. |
artikel |
10 |
Cerebrospinal fluid eosinophils in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease
|
Kornbluh, Alexandra B. |
|
|
85 |
C |
p. |
artikel |
11 |
Characteristics and predictors of sexual dysfunction in men with multiple sclerosis
|
Adamec, Ivan |
|
|
85 |
C |
p. |
artikel |
12 |
Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review
|
Kazzi, Christina |
|
|
85 |
C |
p. |
artikel |
13 |
Cognitive function influences cognitive-motor interference during dual task walking in multiple sclerosis
|
Hsu, Wan-Yu |
|
|
85 |
C |
p. |
artikel |
14 |
Combination of serum markers with optical coherence tomography angiography for evaluating neuromyelitis optica spectrum disorders and multiple sclerosis
|
Liu, Chunxin |
|
|
85 |
C |
p. |
artikel |
15 |
Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study
|
Wanitschek, Andreas |
|
|
85 |
C |
p. |
artikel |
16 |
Contents List
|
|
|
|
85 |
C |
p. |
artikel |
17 |
Disparities in DMT treatment: Demographic and neurocognitive differences between MS patients currently treated versus not treated with disease-modifying therapies
|
Leavitt, Victoria M. |
|
|
85 |
C |
p. |
artikel |
18 |
Do proprioceptive neuromuscular facilitation techniques improve respiratory parameters and swallowing in people with multiple sclerosis: A randomized-controlled study
|
Kesebir, Julide |
|
|
85 |
C |
p. |
artikel |
19 |
Effectiveness of tixagevimab/cilgavimab (Evusheld) in antiCD20‑treated patients with multiple sclerosis and neuromyelitis optica spectrum disorder
|
Stastna, D. |
|
|
85 |
C |
p. |
artikel |
20 |
Efficacy and comparison of corticosteroids only and corticosteroids with plasmapheresis or intravenous immunoglobulin for the treatment of optic neuritis in demyelinating disease: A systematic review and network meta-analysis
|
Gaulier, Arnaud |
|
|
85 |
C |
p. |
artikel |
21 |
Enlarged choroid plexus in relapsing-remitting multiple sclerosis may lead to brain structural changes through the glymphatic impairment
|
Xie, Yan |
|
|
85 |
C |
p. |
artikel |
22 |
Epidemiology of aquaporin-4-IgG-positive NMOSD in Sardinia
|
Sechi, Elia |
|
|
85 |
C |
p. |
artikel |
23 |
Evidence of disease activity during pregnancy and post-partum in MS patients treated with high-efficacy therapies
|
Sahloul, Oussama |
|
|
85 |
C |
p. |
artikel |
24 |
Exclusion of alternative diagnoses: A component of the 2023 MOGAD criteria that belongs at the forefront, not in the background
|
Budhram, Adrian |
|
|
85 |
C |
p. |
artikel |
25 |
Feasibility and tolerability of portable, low-field brain MRI for patients with multiple sclerosis
|
Ham, Andrew Siyoon |
|
|
85 |
C |
p. |
artikel |
26 |
Feasibility study to assess lesion repair in relapsing-remitting multiple sclerosis: A randomized controlled pilot clinical trial of domperidone add-on treatment
|
Zhang, Yunyan |
|
|
85 |
C |
p. |
artikel |
27 |
Functional electrical stimulation combined with voluntary cycling accentuates VO2 response in people with severe multiple sclerosis: A pilot study
|
Máté, Suzanne |
|
|
85 |
C |
p. |
artikel |
28 |
Headache disorders in multiple sclerosis: Is there an association? A systematic review and meta-analysis
|
Gklinos, Panagiotis |
|
|
85 |
C |
p. |
artikel |
29 |
Impact of rituximab treatment regime on time to relapse in aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
|
Nasir, Moneeb |
|
|
85 |
C |
p. |
artikel |
30 |
Intrathecal B cell activation and memory impairment in multiple sclerosis
|
Gaetani, Lorenzo |
|
|
85 |
C |
p. |
artikel |
31 |
Isolated myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in adults: The importance of age of onset and prognosis-related radiological features
|
Zhao, Juan |
|
|
85 |
C |
p. |
artikel |
32 |
Lymphocytic infiltration in multiple sclerosis
|
Mahla, Ranjeet Singh |
|
|
85 |
C |
p. |
artikel |
33 |
Metronomic radiological surveillance in clinically stable MS patients on anti CD20 immunotherapy is redundant
|
Avasarala, Jagannadha |
|
|
85 |
C |
p. |
artikel |
34 |
Multi-actor system dynamics in access to disease-modifying treatments for multiple sclerosis in Southeast Asia: A regional survey and suggestions for improvement
|
Viswanathan, Shanthi |
|
|
85 |
C |
p. |
artikel |
35 |
Multiple Sclerosis Multidisciplinary Care: A National Survey and Lessons for the Global Community
|
Van Hijfte, Liesbeth |
|
|
85 |
C |
p. |
artikel |
36 |
Neonatal outcomes in women with Multiple Sclerosis – Influence of disease activity: A Danish nationwide cohort study
|
Andersen, Mette Louise |
|
|
85 |
C |
p. |
artikel |
37 |
Olfactory threshold as a biomarker of long-term relapse activity in multiple sclerosis
|
Berek, Klaus |
|
|
85 |
C |
p. |
artikel |
38 |
Prognostic factors of tumefactive demyelinating lesions and differential features for multiple sclerosis in etiology
|
Saridas, Furkan |
|
|
85 |
C |
p. |
artikel |
39 |
Role of C5 inhibitors in neuromyelitis optica spectrum disorders with seropositive anti-aquaporin-4 antibody: A systematic review and meta-analysis
|
Makkawi, Seraj |
|
|
85 |
C |
p. |
artikel |
40 |
Seizures in inflammatory demyelinating disorders of the central nervous system
|
Ertürk Çetin, Özdem |
|
|
85 |
C |
p. |
artikel |
41 |
Serum lipids and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis
|
Sanaie, Sarvin |
|
|
85 |
C |
p. |
artikel |
42 |
The association of menopausal hormone levels with progression-related biomarkers in multiple sclerosis
|
Juutinen, Laura |
|
|
85 |
C |
p. |
artikel |
43 |
The clinical and radiological features and prevalence of Neuro-Behçet's Disease: A retrospective cohort multicenter study in Saudi Arabia
|
Makkawi, Seraj |
|
|
85 |
C |
p. |
artikel |
44 |
The discrimination between autoimmune glial fibrillary acidic protein astrocytopathy and tuberculous meningitis
|
Chen, Yanxiang |
|
|
85 |
C |
p. |
artikel |
45 |
The measurement of fatigability severity in individuals with multiple sclerosis and healthy controls
|
Alharbi, Mutasim D. |
|
|
85 |
C |
p. |
artikel |
46 |
The risk of type 2 diabetes mellitus in multiple sclerosis and neuromyelitis optica spectrum disorder: A nationwide cohort study
|
Cho, Eun Bin |
|
|
85 |
C |
p. |
artikel |
47 |
Under & Over: A randomised controlled study to develop an upper limb rehabilitation tool for people with Multiple Sclerosis
|
Thomson, Alison |
|
|
85 |
C |
p. |
artikel |
48 |
What is the importance of family planning in multiple sclerosis? A study in the Brazilian population
|
Melo, Elisa Matias Vieira de |
|
|
85 |
C |
p. |
artikel |
49 |
Where does multiple sclerosis come from?
|
Maltby, VE |
|
|
85 |
C |
p. |
artikel |